Bone Marrow Transplantation News

ASH awarded funding to 19 early-career investigators to support resumption of research paused due to the COVID-19 pandemic.

More than a year into the COVID-19 pandemic, new information emerges daily about the virus and its effects on various vulnerable populations.

The FDA granted priority review to ruxolitinib for the treatment of adults and children aged 12 years or older with steroid-refractory chronic graft-versus-host disease, according to a manufacturer-issued press release.

Total body irradiation plus etoposide improved OS and appeared to reduce risk for relapse among children with high-risk acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant, study results showed.

Combining natural killer cells with high-dose chemotherapy and autologous stem cell transplant did not increase toxicity among patients with B-cell non-Hodgkin lymphoma, according to results presented at TCT Meetings Digital Experience.

Letermovir reduced clinically significant cytomegalovirus reactivation among patients who underwent allogeneic hematopoietic stem cell transplant, according to retrospective results presented at TCT Meetings Digital Experience.

Autologous hematopoietic stem cell transplant conferred favorable 2-year outcomes among older adults with multiple myeloma, according to study results presented at TCT Meetings Digital Experience.

Ruxolitinib appeared more effective than best available therapy for steroid-refractory or steroid-dependent chronic graft-versus-host disease, according to randomized phase 3 study results presented at TCT Meetings Digital Experience.

Use of cryopreserved grafts following reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation appeared associated with poorer outcomes, according to results presented at TCT Meetings Digital Experience.

Respiratory viral infections are becoming a more prevalent concern among clinicians who care for patients who undergo hematopoietic stem cell transplantation, according to findings presented at TCT Meetings Digital Experience.